Mathan Somasundaram of Deep Data Analytics and Howard Coleman from Teaminvest reviewed AR9 on "The Call" today.
Their recommendation was essentially to "avoid" and wait until they start making some profit before even consider investing, and that AR9 is very high risk.
They remarked that the company is too small almost like a private company and looking at market cap and revenue probably shouldn't be publicly listed. They are winning some government contracts lately probably because they are the cheapest tender, which means low profit margin making investors the losers.
For those who subscribe to ******:
https://******.com.au/series/the-call?seriesID=3I guess that lines up with what I was saying - AR9 is running a very high risk strategy.
